Vaccines

Pneumococcal and Flu Vaccine Study

Rochester Clinical Research is currently seeking volunteers to participate in a pneumococcal and flu vaccine study. This study is for people who are 50 years or older and want to protect themselves against these two very contagious viruses before the Winter season. This study is approximately 7 months long and consists of 3 office visits and 4 telephone call check-ins. The purpose of the study is to test the safety and efficacy of the vaccine targeting the two viruses and different stains of the flu. If you qualify to participate, compensation will be provided for your time and travel.

*Compensation for time and travel may be available to those who qualify.

Flu Vaccine Trial

Rochester Clinical Research is currently seeking volunteers who are 18 years and older for an Influenza vaccine study. The purpose of this study will be to evaluate the safety and immunogenicity of an mRNA vaccine to prevent influenza. Compensation for time and travel is available for around $630 to those who qualify.

*Compensation for time and travel may be available to those who qualify.

Covid-19 Omicron Variant Vaccine Trial

Rochester Clinical Research is currently seeking volunteers over the age of 18 to participate in an omicron variant booster vaccine study. This paid research study is testing the efficacy and tolerability of an omicron variant-specific vaccine. The purpose of this vaccine is to provide extra protection against the highly contagious strain. The study is about 6 months long and requires 5 visits to the office.

*Compensation for time and travel may be available to those who qualify.

mRNA Flu Vaccine Study

Rochester Clinical Research is seeking volunteers who are 50 years and older to participate in an mRNA flu vaccine study. The purpose of this study is to evaluate the effectiveness of using mRNA technology in a flu vaccine at protecting against different variants. Since the normal flu vaccines are only about 60% effective, doctors believe that this will result in better protection results. This is a phase 3 study and is about 12 months long with only one visit to our office.

CMV Vaccine

Rochester Clinical Research is currently seeking born-female volunteers between the ages of 16 and 40 years old to participate in a CMV vaccine study. The purpose of this study is to find a safe and effective vaccine against Cytomegalovirus.

RSV Vaccine Study

Rochester Clinical Research is currently seeking adults over the age of 64 years old for different RSV vaccine studies. Join an RSV vaccine study that is testing the efficacy of a vaccine that may prevent lower respiratory tract disease, which is associated with the RSV virus. The study will last about 24 to 30 months and consists up to 6 office visit and a monthly telephone appointment. Compensation may be up to $1,640 for time and travel to participate in the study.

*Compensation for time and travel may be available to those who qualify.

Pneumococcal Vaccine Study

Rochester Clinical Research is now seeking volunteers between the ages of 18 and 49 years old for a Pneumococcal vaccine study. This paid research study hopes to find a new pneumococcal vaccine that will potentially protect against strains not covered by the currently available vaccines. The study is approximately 6 months long and you can get up to $555 in study-related compensation.

*Compensation for time and travel may be available to those who qualify.

Dengue Fever Vaccine Study

Dengue fever is a virus that is carried by mosquitoes, usually in subtropical and tropical climates. Symptoms can range from either being mild or severe. The virus only lasts about a week, but if left untreated it could turn into severe symptoms. We are conducting a phase 2 study of a vaccine for people ages 18-50 years old to test the safety and efficiency of different doses given. It's a one-year-long trial with 8 visits to the office.

*Compensation for time and travel may be available to those who qualify.

Chikungunya Vaccine Study

Chikungunya is a virus that can be spread through mosquito bites similar to other mosquito-spread illnesses like Zika, malaria, dengue, and West Nile Virus. RCR is conducting a study to test the effectiveness of a phase 3 vaccine to prevent Chikungunya in people who are 65 or older. The study will be 7 months long and consists of 5 office visits and 2 phone call appointments.

*Compensation for time and travel may be available to those who qualify.

Migraine Relief Study

Rochester Clinical Research wants to help advance treatments for people who suffer from episodic migraines. We are conducting a study that is three months long and requires you to come in once a month to receive an injection. RCR is seeking healthy individuals between the ages of 18-65 who get 4-14 migraines a month to participate. This is a phase 4 study and Rochester Clinical research wants to help get this treatment FDA-approved so that people no longer have to let migraines slow down their day.

*Compensation for time and travel may be available to those who qualify.